The Third Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong

Public research footprint of The Third Affiliated Hospital of Sun Yat-sen University, compiled from the ClinicalTrials.gov public registry.

176

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Systemic Lupus Erythematosus · Recurrent Head and Neck Squamous Cell Carcinoma · Moderate to Severe Glabellar Lines · Metabolic Dysfunction Associated Steatohepatitis (MASH)

Recently updated registry entries

NCT06937944 — Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to… (Recruiting)
NCT07712705 — HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis. (Completed)
NCT07497087 — A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Third Affiliated Hospital of Sun Yat-sen University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.